JillChristinaAndersonMD

PubMed

• 13 citations
  Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates.
  Wayne C. Levy, Anne S. Hellkamp, Daniel B. Mark, Jeanne E. Poole, Ramin Shadman, Todd F. Dardas, Jill Anderson, George Johnson, Daniel P. Fishbein, Kerry L. Lee, David...> ;JACC. Clinical Electrophysiology. 2018 Jun 27
• 34 citations
  Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
  Kristen K. Patton, Anne S. Hellkamp, Kerry L. Lee, Daniel B. Mark, George Johnson, Jill Anderson, Gust H. Bardy, Jeanne E. Poole, SCD-HeFT Investigators> ;Journal of the American College of Cardiology. 2014 Jun 24
• 15 citations
  Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudd...
  Daniel P. Fishbein, Anne S. Hellkamp, Daniel B. Mark, Mary Norine Walsh, Jeanne E. Poole, Jill Anderson, George Johnson, Kerry L. Lee, Gust H. Bardy, SCD-HeFT Investig...> ;Journal of the American College of Cardiology. 2014 Jun 17
• Masson tumor arising in a congenital vascular anomaly.
  Jill C. Anderson, Katherine K. Brown> ;Pediatric Dermatology. 2013 Nov 1
• Join now to see all